Skip to main content
padlock icon - secure page this page is secure

The Use of Hydrophilic Poly(N,N-dimethylacrylamide) for Promoting Engulfment of Magnetic γ-Fe2O3 Nanoparticles by Mammalian Cells

Buy Article:

$106.67 + tax (Refund Policy)

γ-Fe2O3 nanoparticles obtained by coprecipitation of Fe(II) and Fe(III) chlorides with a base and subsequent oxidation were coated with a shell of hydrophilic biocompatible poly(N,N-dimethylacrylamide) (PDMAAm). Various initiators were attached to the iron oxide surface to enable the use of the “grafting-from” approach for immobilization of PDMAAm. They included 2,2′-azobis(2-methylpropanimidamide) dihydrochloride (AMPA), 2,2′-azobis(N-hydroxy-2-methylpropanimidamide) dihydrochloride (ABHA) and 4-cyano-4-{[1-cyano-3-(N-hydroxycarbamoyl)-1-methylpropyl]azo}pentanoic acid (CCHPA). Engulfment of PDMAAm-coated γ-Fe2O3 nanoparticles by murine J774.2 macrophages was investigated. Only some nanoparticles were engulfed by the macrophages. PDMAAm-AMPA-γ-Fe2O3 and PDMAAm-ABHA-γ-Fe2O3 nanoparticles were rapidly engulfed by the cells. In contrast, neat γ-Fe2O3 and PDMAAm-CCHPA-γ-Fe2O3 particles induced formation of transparent vacuoles indicating toxicity of the particles. Thus, PDMAAm-coated AMPA- and ABHA-γ-Fe2O3 nanoparticles can be recommended as non-toxic labels for mammalian cells.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: ENGULFMENT; MAGHEMITE; MAMMALIAN CELLS; NANOPARTICLES; POLY(N,N-DIMETHYLACRYLAMIDE); SUPERPARAMAGNETIC

Document Type: Research Article

Publication date: March 1, 2013

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more